Skip to Content

M D12 (Doxazosin 8 mg)

Pill imprint M D12 has been identified as Doxazosin mesylate 8 mg.

Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Doxazosin mesylate 8 mg M D12  Front
Doxazosin mesylate 8 mg M D12  Back
Doxazosin mesylate 8 mg M D12
Doxazosin mesylate 8 mg M D12
Doxazosin mesylate
M D12
8 mg
9.00 mm
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
FD&C Blue No. 2
D&C Red No. 30
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
67544-0273 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.